Quarterly Updates2 Nov 2026, 05:10 pm
Cineline India: No Deviation in Fund Utilization for Q2 FY27
AI Summary
Cineline India Limited has filed a statement confirming no deviation or variation in the utilization of proceeds raised from the preferential issue of 38,46,153 Equity Shares via Warrants. The total amount raised was ₹33,74,99,925.75. The funds were intended for business growth, general corporate purposes, and working capital requirements. The Audit Committee has reviewed and approved the NIL statement of deviation for the quarter ended September 30, 2026. The filing adheres to SEBI Listing Regulations.
Key Highlights
- No deviation reported in fund utilization for Q2 FY27.
- Proceeds raised from preferential issue of warrants confirmed as utilized.
- Funds allocated for business growth, general corporate purposes, and working capital.
- Audit Committee reviewed and approved the NIL deviation statement.
Price Impact
More from CINELINE